Increase in Geriatric Population, Boom in Hospital-Acquired Infection Control Industry

NEW YORK - Feb. 20, 2023 - PRLog -- In 2021, the hospital acquired infection control market was valued at $30,224.7 million, and it will likely grow with a CAGR of 1.6% from 2021 to 2030.

By 2030, it is expected to reach $34,909.7 million, primarily due to the surge in the number of surgical procedures. Population with weakened immune systems are more susceptible to nosocomial infections considering their stay in hospital. The elderly and children are more likely to get hospital infections during their stay.

The negligence of hospital staff to follow protocols, including washing hands, avoiding indwelling catheters, and overuse of antibiotics, leads to the expansion of the hospital acquired infection control market. There is a strict need to increase awareness of hospital acquired infections because more people die due to HAIs than car accidents, AIDS or breast cancer. Several measures could be taken to avoid HAIs for people having a long stay in hospital.

Amidst COVID-19, personal hygiene has become a center of concern to control the spread of the virus. People became more aware and started following practices such as sanitization and washing hands more frequently to avoid germs from outside, leading to surge in the hospital acquired infection control market. During this period, the hospital acquired infection control market witnessed a rise. As a hospital, the work hours for hospital staff were at their peak during a pandemic, and infections such as CLABSIs and other medical device-related infections increased.

An increase in clinical surgical processes is witnessed, considering the rise in cardiovascular diseases, neurological disorders and serious injuries, leading to expansion of hospital acquired infection market (https://www.psmarketresearch.com/market-analysis/hospital...). On an average, 20 million people suffer from accidents or neurological illnesses each year, and 14 million people require to undergo surgery. The advent of advanced surgical technologies has eliminated the human error. Types of surgical procedures are introduced in the market, including invasive, less invasive and non-invasive.

The largest share of the hospital acquired infection control market is captured by North America, which continued 35% of the revenue. The strong presence of the key market players in the region, increase in geriatric population and surge in chronic diseases are significant contributors to the dominance of North America in the market. The U.S. population comprises around 45 million people aged more than 65 years, and by 2050, the number is expected to reach above 80 million. Furthermore, approximately 10,000 people die each year due to HAIs in American hospitals.

Thus, the increased prevalence of HAIs boosts the market to prevent nosocomial infections. People with weakened immune systems are more likely to counter infections during their hospital stay.